Cardiovascular diseases are the leading cause of death in almost
40% of patients suffering from end stage renal disease (ESRD).
Cardiomyopathy and ischemic heart disease are the most frequent
causes of cardiac death. The risk of cardiovascular mortality in
dialysis patients is 10 to 20 times greater than the general
population, particularly in younger patients, taking into account
that the relative risk decreases with age. Left ventricular
hypertrophy (LVH) is the most common cardiac abnormality in chronic
kidney disease (CKD), and the survival risk ratio in such patients
is independent. This book examines the molecular mechanisms,
treatments and clinical implication of cardiac remodeling. The
first chapter discusses risk factors for cardiovascular disease in
patients on continuous ambulatory peritoneal dialysis. The
following chapters examine the impacts tropomyosin, vitamin D, and
coffee have on cardiac remodeling.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!